rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors

Clinical trial NCT00902122 · UNKNOWN

Trial details

NCT number: NCT00902122
Sponsor: Shenzhen SiBiono GeneTech Co.,Ltd
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Advanced Malignant Thyroid Tumors

Start date: 2009-05-01
Primary completion: 2012-08-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.